Advertisement
Canada markets closed
  • S&P/TSX

    22,167.03
    +59.95 (+0.27%)
     
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • DOW

    39,807.37
    +47.29 (+0.12%)
     
  • CAD/USD

    0.7384
    +0.0012 (+0.16%)
     
  • CRUDE OIL

    82.99
    +1.64 (+2.02%)
     
  • Bitcoin CAD

    95,735.55
    +2,350.01 (+2.52%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,241.00
    +28.30 (+1.28%)
     
  • RUSSELL 2000

    2,124.55
    +10.20 (+0.48%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • NASDAQ

    16,379.46
    -20.06 (-0.12%)
     
  • VOLATILITY

    12.99
    +0.21 (+1.64%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • CAD/EUR

    0.6841
    +0.0036 (+0.53%)
     

Agile Therapeutics: 4Q Earnings Snapshot

PRINCETON, N.J. (AP) _ Agile Therapeutics Inc. (AGRX) on Monday reported a loss of $17.6 million in its fourth quarter.

The Princeton, New Jersey-based company said it had a loss of 20 cents per share.

The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 23 cents per share.

The developer of prescription contraceptive products for women posted revenue of $749,000 in the period, which did not meet Street forecasts. Three analysts surveyed by Zacks expected $1 million.

For the year, the company reported that its loss widened to $51.9 million, or 61 cents per share. Revenue was reported as $749,000.

ADVERTISEMENT

In the final minutes of trading on Monday, the company's shares hit $3.02. A year ago, they were trading at $2.74.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AGRX at https://www.zacks.com/ap/AGRX